Nontuberculous mycobacterium infection in a burn ICU patient by Boyer, Joseph M. et al.
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
US Army Research U.S. Department of Defense 
2010 
Nontuberculous mycobacterium infection in a burn ICU patient 
Joseph M. Boyer 
San Antonio Military Medical Center (SAMMC) 
Peter J. Blatz 
San Antonio Military Medical Center (SAMMC) 
Kevin S. Akers 
San Antonio Military Medical Center (SAMMC) 
Jason F. Okulicz 
San Antonio Military Medical Center (SAMMC) 
Kevin K. Chung 
US Army Institute of Surgical Research (USAISR) 
See next page for additional authors 
Follow this and additional works at: https://digitalcommons.unl.edu/usarmyresearch 
 Part of the Operations Research, Systems Engineering and Industrial Engineering Commons 
Boyer, Joseph M.; Blatz, Peter J.; Akers, Kevin S.; Okulicz, Jason F.; Chung, Kevin K.; Rentz, Evan M.; 
Hospenthal, Duane R.; and Murray, Clinton K., "Nontuberculous mycobacterium infection in a burn ICU 
patient" (2010). US Army Research. 113. 
https://digitalcommons.unl.edu/usarmyresearch/113 
This Article is brought to you for free and open access by the U.S. Department of Defense at 
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in US Army Research by an 
authorized administrator of DigitalCommons@University of Nebraska - Lincoln. 
Authors 
Joseph M. Boyer, Peter J. Blatz, Kevin S. Akers, Jason F. Okulicz, Kevin K. Chung, Evan M. Rentz, Duane R. 
Hospenthal, and Clinton K. Murray 
This article is available at DigitalCommons@University of Nebraska - Lincoln: https://digitalcommons.unl.edu/
usarmyresearch/113 
Case report
Nontuberculous mycobacterium infection in a burn ICU
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bUS Army Institute of Surgical Research (USAISR), United States
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1. Introduction
Infection is a leading cause of mortality in burn patients,
typically due to bacterial pathogens such as Staphylococcus
aureus and Pseudomonas aeruginosa, less commonly fungi, and
possibly viruses [1–4]. In non-burn patients with underlying
pulmonary or cutaneous disease, nontuberculous mycobac-
teria (NTM) have become an increasingly recognized cause of
infection, especially in patients who are immunocompro-
mised [5]. Patients with severe burns might have higher rates
of NTM infections due to inherent risks associated with the
burn injury: compromised skin integrity, immunocompro-
mised state, inhalation injury, and frequent use of indwelling
vascular catheters. To date there have been no reports
describing the incidence of mycobacterial infections in burn
patients. We describe a case of Mycobacterium abscessus
bacteremia and clinical record review of patients admitted
to the US Department of Defense burn center with severe
burns for other evidence of NTM infections from 1 May 2000 to
30 April 2009.
2. Case report
A 52-year-old male patient suffered a 65% total body surface
area (TBSA) burn from an explosive device in Iraq. At the time
of injury, he underwent an emergent crichothyroidotomy, was
intubated, and transferred to Landstuhl Regional Medical
Center (LRMC) in Germany. The patient was stabilized at LRMC
and subsequently evacuated to the US Army Institute of
Surgical Research (USAISR) burn intensive care unit at Brooke
Army Medical Center (BAMC) for definitive care.
The patient had no significant past medical or surgical
history, and was not taking any medications at the time of his
injury. The patient underwent initial excision and grafting
with available autograft, temporary coverage with homograft
and subsequent serial autograft placement. Topical wound
dressings utilized 5% sulfamyalon soaks initially as well as
silver nylon dressings following autograft placement; approx-
imately 10% TBSA remained open following grafting opera-
tions. The patient’s hospital course was complicated with
multiple episodes of sepsis including sepsis with multidrug-
resistant P. aeruginosa and Enterobacter cloacae which required
repeated courses of broad spectrum antibiotics including
colistimethate, vancomycin, and imipenem. Central lines
were changed to a new site at least every 7 days or earlier
for suspected line-related infection. Standard aerobic cultures
of blood obtained on hospital days (HD) 72 and 79 produced
growth of acid-fast bacilli (AFB). Prior to this first recovery of
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AFB from blood culture obtained on HD 72, a total of 9
cutaneous tissue specimens performed on HD 2, 6 and 14 were
negative for AFB by specific staining and culture. Multiple
tracheal aspirates and bronchial alveolar lavages (BAL) speci-
mens grew various bacteria but did not reveal evidence of AFB.
On HD 87, preliminary laboratory testing from one of the blood
AFB isolates revealed a suspected rapid-growing mycobacte-
rium and empiric antimicrobial therapy with tobramycin and
azithromycin was added to his current imipenem. Tracheal
aspirates cultured on HD 89 and 90 also produced AFB.
Unfortunately, the patient succumbed to his injuries and
complications on HD 100. The blood cultures from HD 72 and
79 as well as tracheal aspirate cultures from HD 89 and 90 grew
M. abscessus, which was confirmed by biochemical and
mycolic acid analysis performed at National Jewish Health,
Denver, CO. Antimicrobial susceptibility testing of the isolate
revealed susceptibility to amikacin and clarithromycin, but
resistance to ciprofloxacin, linezolid, and tobramycin. The
imipenem MIC was 8 mg/mL (no interpretive criteria available).
Autopsy revealed diffuse interstitial pulmonary fibrosis as
well as extensive pulmonary hemorrhage, but no organisms
were seen on microscopy. Integumentary pathology revealed
intraepidermal gram positive and gram negative bacterial
colonies focally invading the dermis, with multiple organisms
cultured from the burn wounds including Stenotrophomonas
maltophilia, P. aeruginosa, S. aureus, Micrococcus sp., and Group B
Streptococcus. Mycobacteria did not grow from post-mortem
cultures. AFB staining was not performed on specimens
obtained at autopsy; however, standard stains of all autopsy
samples did not identify any pathogen consistent with a
mycobacterial species.
3. Review of the incidence of mycobacterial
infections
After obtaining institutional review board approval, we
performed a retrospective electronic records review of
patients admitted to the USAISR burn center for treatment
of thermal burns for those demonstrating culture growth of
mycobacteria; patients without thermal burns were excluded
from the study. The standard approach to care of burn patients
at our institution includes early burn wound excision and
grafting, early bronchoscopy for suspected inhalation injury
and aggressive infection control interventions [6].
Using electronic medical records, culture results for the
period of 1 May 2000 through 30 April 2009 were screened for
Mycobacterium species. Culture sites included sputum, BAL
fluid, blood, urine, skin, and cerebrospinal fluid. Demographic
data, comorbid conditions and potential risk factors were
characterized for patients with culture growth of mycobac-
teria. To differentiate between colonization and infection, the
clinical and microbiologic criteria set forth by the American
Thoracic Society (ATS) and Infectious Disease Society of
America (IDSA) were used [5]. Clinical criteria include
pulmonary symptoms, nodular or cavitary opacities on chest
radiograph or multifocal bronchiectasis seen on high resolu-
tion computed tomography and appropriate exclusion of other
diagnoses [5]. Microbiologic criteria include either culture
results from at least two expectorated samples, culture from at
least one BAL, or lung histopathology demonstrating myco-
bacterial organisms and NTM growth in culture. Criteria for
disseminated disease included growth from blood or bone
marrow cultures [5].
During the study period, 2428 patients with thermal burns
were admitted to the USAISR burn center. The median TBSA
burn was 9% (range 0.1–99%), median age was 31 (range 15–
100) and the median injury severity score (ISS) was 4 (range 0–
75). The majority of the patients were male (2051, 84%).
Inhalational injury was seen in 287 patients (11.8%).
From this cohort, only 8 patients (including our case
report), with a total of 14 cultures, had growth of NTMs
(Table 1). Of these, 7 were male. The median TBSA burn was
24.8% (range 4.5–72.5%) with a median age of 50 years (range
18–79). Inhalational injury was diagnosed in 3 patients and
only 2 patients sustained burns during military operations.
Nontuberculous mycobacteria were isolated from the sputa
of 7 patients, one patient had NTM recovered in gastric
aspirate culture and one patient had NTM isolated from blood
culture. The most common NTM were Mycobacterium avium
complex (MAC) and Mycobacterium simiae: isolated in 5 and 4
patients, respectively. M. gordonae, M. fortuitum, and M.
abscessus were each isolated in single patients. Of the 8 total
patients with NTM isolates, 5 patients had a documented
history of active tobacco use at the time of admission. Two
patients reported active recreational drug use (1 heroin, 1
marijuana) and two patients had a history of chronic
obstructive pulmonary disease (COPD). One patient reported
a history of treated pulmonary tuberculosis. With exception
to our case patient, no other patient met ATS/IDSA criteria for
NTM infection.
4. Discussion
Infections are the primary cause of mortality among burn
patients after recovery from the initial burn injury. Although
patients with severe burns have risk factors that may increase
their risk of developing NTM infections, our 9-year review of
2428 admissions to a single burn unit revealed only 1 patient
with definite NTM infection. To our knowledge, this is the first
reported case of NTM infection in a burn patient.
Mycobacteria are gram-positive, acid-fast bacteria, which
can cause a wide variety of clinical syndromes including
pulmonary disease, skin and soft tissue infection, and rarely
bacteremia. M. tuberculosis, M. kansasii, M. avium complex and
M. chelonae are typically associated with pulmonary disease
while M. marinum, M. ulcerans and the rapidly growing
mycobacteria (M. fortuitum, M. abscessus, and M. chelonae) are
typically associated with skin and soft tissue infections.
Rapidly growing mycobacteria are of great interest as these
NTM are a group of environmental organisms which can cause
disease in humans. These organisms commonly cause
localized skin and soft tissue infections [7], intravascular
catheter infections [8], disseminated infection, osteomyelitis,
peritonitis [9,10], endocarditis [11], and bacteremia [12].
Although infections with this group of organisms may occur
sporadically, outbreaks have also been reported. Nosocomial
outbreaks due to M. abscessus are most commonly described;
the majority of which have been traced to contaminated
b u r n s 3 6 ( 2 0 1 0 ) e 1 3 6 – e 1 3 9 e137
liquids including water and sterile solutions [13]. Environ-
mental contamination has also been associated with a small
cluster of NTM where the origin of the organism was
attributed to dust generated from building construction [12].
Although our patient did have multiple risk factors for a
nosocomial source, it is unlikely that a contaminant outbreak
occurred at our facility as no other cases were identified either
before or after our patient was hospitalized.
Although severely burned patients may be at increased risk
for NTM infection because of their injury, these infections
were not common in thermal burn patients in our facility.
Limitations of the study include the lack of routine screening
for mycobacterial infections. However, traditional culture and
histological techniques should have enabled us to detect
either outbreaks with NTM or ongoing infections. Overall,
infections caused by NTM appear to be rare in burn patients
and routine screening or testing for mycobacteria is not
required. However, infections with NTM should remain in the
differential diagnosis for patients failing to clinically improve
despite appropriate identification and treatment of typical
bacterial and fungal pathogens associated with burns.
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